#mash

Metabolic Dysfunction-Associated Steatohepatitis Clinical Trial and Competitive Landscape Expands as 180+ Companies Target New Treatment Options | DelveInsight

The competitive landscape for Metabolic Dysfunction-Associated Steatohepatitis (MASH) treatments is expanding, with over 180 companies actively pursuing new therapeutic options. This indicates a growing focus and investment in addressing this liver condition.